Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
2(25%)
Results Posted
0%(0 trials)
Terminated
1(13%)

Phase Distribution

Ph phase_4
3
38%
Ph phase_2
1
13%
Ph not_applicable
3
38%

Phase Distribution

0

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
1(14.3%)
Phase 4Post-market surveillance
3(42.9%)
N/ANon-phased studies
3(42.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

8

all time

Status Distribution
Active(2)
Completed(4)
Terminated(1)
Other(1)

Detailed Status

Completed4
Recruiting2
unknown1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
2
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (14.3%)
Phase 43 (42.9%)
N/A3 (42.9%)

Trials by Status

unknown113%
completed450%
recruiting225%
terminated113%

Recent Activity

2 active trials
Showing 5 of 8
recruitingnot_applicable

The Role of Skin Sodium Accumulation in Chronic Kidney Disease

NCT07020104
recruiting

Bariatric Surgery and Pharmacokinetics of Lercanidipine

NCT03497156
completedphase_4

Zainidip in Renal Artery Stenosis

NCT02594410
completedphase_4

Intensive Vasodilator Therapy in Patients With Essential Hypertension

NCT01180413
completedphase_2

Efficacy and Safety of Lercanidipine and Enalapril in Patients With Essential Hypertension

NCT01093807
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT07020104Not Applicable

The Role of Skin Sodium Accumulation in Chronic Kidney Disease

Recruiting
NCT03497156

Bariatric Surgery and Pharmacokinetics of Lercanidipine

Recruiting
NCT02594410Phase 4

Zainidip in Renal Artery Stenosis

Completed
NCT01180413Phase 4

Intensive Vasodilator Therapy in Patients With Essential Hypertension

Completed
NCT01093807Phase 2

Efficacy and Safety of Lercanidipine and Enalapril in Patients With Essential Hypertension

Completed
NCT00424801Not Applicable

Effects of Intensive Long-Term Vasodilation in Hypertensive Patients With Microvascular Angina Pectoris

Terminated
NCT00160498Not Applicable

Testing the Efficacy of Different Dosages of Lercanidipine to Reduce Hypertensive Blood Pressure in Normal Weight and Obese Patients

Completed
NCT00564057Phase 4

Effects of Antihypertensive Treatment in HIV Infected Patients: Candesartan Versus Lercanidipine

Unknown

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8